International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Interview with young scientist, Samiksha Ghimire

S. Ghimire

Last year I read a really impressive contribution to the Compass from young scientist, Samiksha Ghimire. She described her ambitious PhD project which aimed to implement and evaluate a TDM programme for anti-tuberculosis drugs in Nepal, an endemic setting, using alternative sampling strategies. I was literally on the edge of my seat reading this piece, impressed at the high relevance of the project, especially since Nepal is her home country, and also Samiksha’s clarity and maturity as a PhD student: I won’t give away how the piece concludes, but want to highlight that I found it very impressive the way that Samiksha faced the very real challenges that emerged in the project at that point in time. This month we hear from Samiksha, and, again, I was very impressed with her orientation with innovative technologies in TDM, some of which we haven’t heard about before in these interviews. In my search for Samiksha’s email, I came across the story of how she became an Eric Bleumink Fund Scholar, which is also very impressive. Congratulations on your achievements Samiksha!


Samiksha Ghimire

University Medical Center Groningen

University of Groningen, Groningen, the Netherlands

Interview with Marina Venzon Antunes

Marina Venzon Antunes

This month we hear from Marina Venzon Antunes, young scientist and co-chair of the upcoming IATDMCT Congress in Foz do Iguaçu, Brazil. Marina shares about her work at the Feevale University where they are developing various assays and approaches using alternative sampling strategies, in the aim to facilitate access in a context where her lab is one of few reference centres for TDM in the country.


Marina Venzon Antunes

Professor of Biomedicine

Feevale University, Novo Hamburgo, Brazil

November Blog: Approach to chemotherapy dosing in the obese child: an ongoing challenge

Jennifer Martin

This month we highlight a piece in the September Compass by Jessica Ryan and Jenny Martin, written on behalf of the TDM in Oncology Committee. It is an overview on approaches to chemotherapy dosing in the obese child that brings together data from several reviews. Clearance of some drugs is affected while for others it appears not to be. Further, adiposity may influence tumour responsiveness to chemotherapy. However, the authors highlight the lack of data specific to this special population which is becoming more prevalent.


Jessica Ryan and Jennifer Martin

University of Newcastle and Hunter New England Health

Newcastle, Australia

Interview with Sophie Stocker

Sophie Stocker

Sophie Stocker shares about her research aimed at answering clinically relevant questions, often posed in the course of work by hospital staff. Look out for two oral presentations of Sophie's contributed work at the congress, 'A time and motion study of phlebotomists’ work' and 'Vancomycin: Improving prescribing practices', as well as a presentation in the Symposium ‘Emerging TDM technologies and obstacles to widespread use’ on Wednesday (see preliminary program).


Sophie Stocker

Senior Scientific Officer, Department of Clinical Pharmacology & Toxicology, St Vincent’s Hospital

Conjoint Senior Lecturer, St Vincent’s Clinical School, University of NSW, Sydney, AU

Page 8 of 21

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.